The utility of animal models in understanding links between psychosocial processes and cardiovascular health

Social and Personality Psychology Compass

Volumn 5, Issue 4, 2011, Pages 164-179

  Grippo, Angela J ^a  

^a NORTHERN ILLINOIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959617653     PISSN: None     EISSN: 17519004     Source Type: Journal    
DOI: 10.1111/j.1751-9004.2011.00342.x     Document Type: Article

References (146)

1. American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders (4th edn), text revision. Washington, DC: American Psychiatric Association.
2. Amico, J. A., Mantella, R. C., Vollmer, R. R., & Li, X. (2004). Anxiety and stress responses in female oxytocin deficient mice. Journal of Neuroendocrinology, 16, 319-324.
3. Anisman, H., & Matheson, K. (2005). Stress, depression, and anhedonia: Caveats concerning animal models. Neuroscience and Biobehavioral Reviews, 29, 525-546.
4. Arletti, R., & Bertolini, A. (1987). Oxytocin acts as an antidepressant in two animal models of depression. Life Sciences, 41, 1725-1730.
5. Badoer, E. (2001). Hypothalamic paraventricular nucleus and cardiovascular regulation. Clinical and Experimental Pharmacology and Physiology, 28, 95-99.
6. Bairey Merz, C. N., Dwyer, J., Nordstrom, C. K., Walton, K. G., Salerno, J. W., & Schneider, R. H. (2002). Psychosocial stress and cardiovascular disease: Pathophysiological links. Behavioral Medicine, 27, 141-147.
7. Barefoot, J. C., & Schroll, M. (1996). Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation, 93, 1976-1980.
8. Bartolomucci, A., Palanza, P., Costoli, T., Savani, E., Laviola, G., Parmigiani, S. et al. (2003). Chronic psychosocial stress persistently alters autonomic function and physical activity in mice. Physiology and Behavior, 80, 57-67.
9. Barton, D. A., Dawood, T., Lambert, E. A., Esler, M. D., Haikerwal, D., Brenchley, C. et al. (2007). Sympathetic activity in major depressive disorder: Identifying those at increased cardiac risk? Journal of Hypertension, 25, 2117-2124.
10. Berkman, L. F., Melchior, M., Chastang, J. F., Niedhammer, I., Leclerc, A., & Goldberg, M. (2004). Social integration and mortality: A prospective study of French employees of Electricity of France-Gas of France: The GAZEL Cohort. American Journal of Epidemiology, 159, 167-174.
11. Berman, R. M., Belanoff, J. K., Charney, D. S., & Schatzberg, A. F. (1999). Principles of the pharmacotherapy of depression. In D. S. Charney, E. J. Nestler & B. S. Bunney (Eds.), Neurobiology of Mental Illness (pp. 419-432). New York: Oxford University Press.
12. Bosch, O. J., Nair, H. P., Ahern, T. H., Neumann, I. D., & Young, L. J. (2009). The CRF system mediates increased passive stress-coping behavior following the loss of a bonded partner in a monogamous rodent. Neuropsychopharmacology, 34, 1406-1415.
13. Cacioppo, J. T., & Hawkley, L. C. (2003). Social isolation and health, with an emphasis on underlying mechanisms. Perspectives in Biology and Medicine, 46(Suppl 3), S39-S52.
14. Cacioppo, J. T., Hawkley, L. C., Crawford, L. E., Ernst, J. M., Burleson, M. H., Kowalewski, R. B. et al. (2002). Loneliness and health: Potential mechanisms. Psychosomatic Medicine, 64, 407-417.
15. Callus, E., Quadri, E., & Chessa, M. (2010). Elements of psychocardiology in the psychosocial handling of adults with congenital heart disease. Frontiers in Psychology, 1, 1-6.
16. Carney, R. M., & Freedland, K. E. (2003). Depression, mortality, and medical morbidity in patients with coronary heart disease. Biological Psychiatry, 54, 241-247.
17. Carney, R. M., Freedland, K. E., Rich, M. W., Smith, L. J., & Jaffe, A. S. (1993). Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. American Journal of Medicine, 95, 23-28.
18. Carney, R. M., Freedland, K. E., Stein, P. K., Skala, J. A., Hoffman, P., & Jaffe, A. S. (2000). Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosomatic Medicine, 62, 639-647.
19. Carney, R. M., Saunders, R. D., Freedland, K. E., Stein, P., Rich, M. W., & Jaffe, A. S. (1995). Association of depression with reduced heart rate variability in coronary artery disease. American Journal of Cardiology, 76, 562-564.
20. Carroll, B. J., Curtis, G. C., & Mendels, J. (1976). Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. Archives of General Psychiatry, 33, 1051-1058.
21. Carter, C. S. (1998). Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinology, 23, 779-818.
22. Carter, C. S., & Altemus, M. (2005). Oxytocin, vasopressin and depression. In J. A. den Boer, M. S. George & G. J. Ter Horst (Eds.), Current and Future Developments in Psychopharmacology (pp. 201-216). Amsterdam: Benecke N. I.
23. Carter, C. S., DeVries, A. C., & Getz, L. L. (1995). Physiological substrates of mammalian monogamy: The prairie vole model. Neuroscience and Biobehavioral Reviews, 19, 303-314.
24. Carter, C. S., & Keverne, E. B. (2002). The neurobiology of social affiliation and pair bonding. Hormones, Brain and Behavior, 1, 299-337.
25. Cassidy, E. M., & O'Keane, V. (2000). Depression and interferon-alpha therapy. British Journal of Psychiatry, 176, 494.
26. Connor, T. J., & Leonard, B. E. (1998). Depression, stress, and immunological activation: The role of cytokines in depressive disorders. Life Sciences, 62, 583-606.
27. Cryan, J. F., & Slattery, D. A. (2007). Animal models of mood disorders: Recent developments. Current Opinion in Psychiatry, 20, 1-7.
28. Cryan, J. F., Valentino, R. J., & Lucki, I. (2005). Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neuroscience and Biobehavioral Reviews, 29, 547-569.
29. Cunningham., E. T. Jr, & De Souza, E. B. (1993). Interleukin 1 receptors in the brain and endocrine tissues. Immunology Today, 14, 171-176.
30. Dantzer, R. (2006). Cytokine, sickness behavior, and depression. Neurologic Clinics, 24, 441-460.
31. Dantzer, R., Bluthé, R. M., Gheusi, G., Cremona, S., Layé, S., Parnet, P. et al. (1998). Molecular basis of sickness behavior. Annals of the New York Academy of Sciences, 856, 132-138.
32. Das, U. N. (2000). Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Molecular and Cellular Biochemistry, 215, 145-152.
33. Dawood, T., Lambert, E. A., Barton, D. A., Laude, D., Elghozi, J.-L., Esler, M. D. et al. (2007). Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk. Hypertension Research, 30, 285-293.
34. De La Garza, R. II. (2005). Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: Focus on anhedonia. Neuroscience and Biobehavioral Reviews, 29, 761-770.
35. Dunn, A. J., Swiergiel, A. H., & de Beaurepaire, R. (2005). Cytokines as mediators of depression: What can we learn from animal studies? Neuroscience and Biobehavioral Reviews, 29, 891-909.
36. Dunn, A. J., Wang, J., & Ando, T. (1999). Effects of cytokines on cerebral neurotransmission: Comparison with the effects of stress. In R. Dantzer, E. E. Wollmann & R. Yirmiya (Eds.), Cytokines, Stress, and Depression (pp. 117-127). New York: Kluwer Academic/Plenum.
37. Eng, P. M., Rimm, E. B., Fitzmaurice, G., & Kawachi, I. (2002). Social ties and change in social ties in relation to subsequent total and cause-specific mortality and coronary heart disease incidence in men. American Journal of Epidemiology, 155, 700-709.
38. Esler, M., & Kaye, D. (2000). Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. Journal of Cardiovascular Pharmacology, 35(Suppl. 4), S1-S7.
39. Evans, D. L., & Charney, D. (2004). Mood disorders and medical illness: A major public health concern. Biological Psychiatry, 54, 177-180.
40. Felder, R. B., Francis, J., Zhang, Z. H., Wei, S. G., Weiss, R. M., & Johnson, A. K. (2003). Heart failure and the brain: New perspectives. American Journal of Physiology-Regulatory Integrative and Comparative Physiology, 284, R259-R276.
41. Ferrari, R. (1999). The role of TNF in cardiovascular disease. Pharmacological Research, 40, 97-105.
42. Francis, J., Weiss, R. M., Johnson, A. K., & Felder, R. B. (2003). Central mineralocorticoid receptor blockade decreases plasma TNF-α after coronary artery ligation in rats. American Journal of Physiology-Regulatory Integrative and Comparative Physiology, 284, R328-R335.
43. Francis, J., Weiss, R. M., Wei, S. G., Johnson, A. K., & Felder, R. B. (2001). Progression of heart failure after myocardial infarction in the rat. American Journal of Physiology-Regulatory Integrative and Comparative Physiology, 281, R1734-R1745.
44. Francis, J., Zhang, Z. H., Weiss, R. M., & Felder, R. B. (2004). Neural regulation of the proinflammatory cytokine response to acute myocardial infarction. American Journal of Physiology-Heart and Circulatory Physiology, 287, H791-H797.
45. Frasure-Smith, N., & Lespérance, F. (2003). Depression and other psychological risks following myocardial infarction. Archives of General Psychiatry, 60, 627-636.
46. Frasure-Smith, N., Lespérance, F., & Talajic, M. (1995). Depression and 18-month prognosis after myocardial infarction. Circulation, 91, 999-1005.
47. Frazer, A., & Morilak, D. A. (2005). What should animal models of depression model? Neuroscience and Biobehavioral Reviews, 29, 515-523.
48. Freedland, K. E., Miller, G. E., & Sheps, D. S. (2006). The great debate, revisited. Psychosomatic Medicine, 68, 179-184.
49. Freedland, K. E., Rich, M. W., Skala, J. A., Carney, R. M., Dávila-Román, V. G., & Jaffe, A. S. (2003). Prevalence of depression in hospitalized patients with congestive heart failure. Psychosomatic Medicine, 65, 119-128.
50. Froger, N., Palazzo, E., Boni, C., Hanoun, N., Saurini, F., Joubert, C. et al. (2004). Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. Journal of Neuroscience, 24, 2787-2796.
51. Fumeron, F., Betoulle, D., Nicaud, V., Evans, A., Kee, F., Ruidavets, J. B. et al. (2002). Serotonin transporter gene polymorphism and myocardial infarction: Etude Cas-Temoins de l'Infarctus du Myocarde (ECTIM). Circulation, 105, 2943-2945.
52. Garlow, S. J., & Nemeroff, C. B. (2004). The neurochemistry of mood disorders: Clinical studies. In D. S. Charney & E. J. Nestler (Eds.), Neurobiology of Mental Illness (2nd edn, pp. 440-460). New York: Oxford University Press.
53. Getz, L. L., Carter, C. S., & Gavish, L. (1981). The mating system of the prairie vole, Microtus ochrogaster: Field and laboratory evidence for pair bonding. Behavioral Ecology and Sociobiology, 8, 189-194.
54. Glassman, A. H. (1998). Cardiovascular effects of antidepressant drugs: Updated. International Clinical Psychopharmacology, 13(Suppl. 5), S25-S30.
55. Glassman, A. H. (2007). Depression and cardiovascular comorbidity. Dialogues in Clinical Neuroscience, 9, 9-17.
56. Grippo, A. J., Beltz, T. G., & Johnson, A. K. (2003a). Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiology and Behavior, 78, 703-710.
57. Grippo, A. J., Beltz, T. G., Weiss, R. M., & Johnson, A. K. (2006). The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia. Biological Psychiatry, 59, 309-316.
58. Grippo, A. J., Francis, J., Beltz, T. G., Felder, R. B., & Johnson, A. K. (2005a). Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiology and Behavior, 84, 697-706.
59. Grippo, A. J., Francis, J., Weiss, R. M., Felder, R. B., & Johnson, A. K. (2003b). Cytokine mediation of experimental heart failure-induced anhedonia. American Journal of Physiology-Regulatory Integrative and Comparative Physiology, 284, R666-R673.
60. Grippo, A. J., Gerena, D., Huang, J., Kumar, N., Shah, M., Ughreja, R. et al. (2007a). Social isolation induces behavioral and neuroendocrine disturbances relevant to depression in female and male prairie voles. Psychoneuroendocrinology, 32, 966-980.
61. Grippo, A. J., Lamb, D. G., Carter, C. S., & Porges, S. W. (2007b). Social isolation disrupts autonomic regulation of the heart and influences negative affective behaviors. Biological Psychiatry, 62, 1162-1170.
62. Grippo, A. J., Moffitt, J. A., & Johnson, A. K. (2002). Cardiovascular alterations and autonomic imbalance in an experimental model of depression. American Journal of Physiology-Regulatory Integrative and Comparative Physiology, 282, R1333-R1341.
63. Grippo, A. J., Santos, C. M., Johnson, R. F., Beltz, T. G., Martins, J. B., Felder, R. B. et al. (2004). Increased susceptibility to ventricular arrhythmias in a rodent model of experimental depression. American Journal of Physiology-Heart and Circulatory Physiology, 286, H619-H626.
64. Grippo, A. J., Sgoifo, A., Mastorci, F., McNeal, N., & Trahanas, D. M. (2010). Cardiac dysfunction and hypothalamic activation during a social crowding stressor in prairie voles. Autonomic Neuroscience: Basic and Clinical, 156, 44-50.
65. Grippo, A. J., Sullivan, N. R., Damjanoska, K. J., Crane, J. W., Carrasco, G. A., Shi, J. et al. (2005b). Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats. Psychopharmacology, 179, 769-780.
66. Grippo, A. J., Trahanas, D. M., Zimmerman II, R. R., Porges, S. W., & Carter, C. S. (2009). Oxytocin protects against negative behavioral and autonomic consequences of long-term social isolation. Psychoneuroendocrinology, 34, 1542-1553.
67. Grippo, A. J., Wu, K. D., Hassan, I., & Carter, C. S. (2008). Social isolation in prairie voles induces behaviors relevant to negative affect: Toward the development of a rodent model focused on co-occurring depression and anxiety. Depression and Anxiety, 25, E17-E26.
68. Hamm., T. E. Jr, Kaplan, J. R., Clarkson, T. B., & Bullock, B. C. (1983). Effects of gender and social behavior on the development of coronary artery atherosclerosis in cynomolgus macaques. Atherosclerosis, 48, 221-233.
69. Hawkley, L. C., Bosch, J. A., Engeland, C. G., Marucha, P. T., & Cacioppo, J. T. (2007). Loneliness, dysphoria, stress, and immunity: A role for cytokines. In N. P. Plotnikoff, R. E. Faith, A. J. Murgo & R. A. Good (Eds.), Cytokines: Stress and Immunity (2nd edn, pp. 67-85). Boca Raton, FL: CRC Press.
70. Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003). Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biological Psychiatry, 54, 1389-1398.
71. Holst, S., Uvnäs-Moberg, K., & Petersson, M. (2002). Postnatal oxytocin treatment and postnatal stroking of rats reduce blood pressure in adulthood. Autonomic Neuroscience: Basic and Clinical, 99, 85-90.
72. Insel, T. R., & Wintink, A. J. (1991). Central administration of oxytocin modulates the infant rat's response to social isolation. European Journal of Pharmacology, 203, 149-152.
73. Jankowski, M., Bissonauth, V., Gao, L., Gangal, M., Wang, D., Danalache, B. et al. (2010). Anti-inflammatory effect of oxytocin rat myocardial infarction. Basic Research in Cardiology, 105, 205-218.
74. Johnson, A. K., & Anderson, E. A. (1990). Stress and arousal. In J. T. Cacioppo & L. G. Tassinary (Eds.), Principles of Psychophysiology: Physical, Social, and Inferential Elements (pp. 216-252). Cambridge: Cambridge University Press.
75. de Jonge, P., Rosmalen, J. G. M., Kema, I. P., Doornbos, B., van Melle, J. P., Pouwer, F. et al. (2010). Psychophysiological biomarkers explaining the association between depression and prognosis in coronary artery patients: A critical review of the literature. Neuroscience and Biobehavioral Reviews, 35, 84-90.
76. Kannel, W. B., Kannel, C., Paffenbarger, R. S. Jr, & Cupples, L. A. (1987). Heart rate and cardiovascular mortality: The Framingham study. American Heart Journal, 113, 1489-1494.
77. Kapadia, S., Dibbs, Z., Kurrelmeyer, K., Karla, D., Seta, Y., Wang, F. et al. (1998). The role of cytokines in the failing human heart. Cardiology Clinics, 16, 645-656.
78. Kaplan, G. A., Salonen, J. T., Cohen, R. D., Brand, R. J., Syme, S. L., & Puska, P. (1988). Social connections and mortality from all causes and from cardiovascular disease: Prospective evidence from eastern Finland. American Journal of Epidemiology, 128, 370-380.
79. Katz, R. (1982). Animal model of depression: Pharmacological sensitivity of a hedonic deficit. Pharmacology, Biochemistry and Behavior, 16, 965-968.
80. Khaykin, Y., Dorian, P., Baker, B., Shapiro, C., Sandor, P., Mironov, D. et al. (1998). Autonomic correlates of antidepressant treatment using heart-rate variability analysis. Canadian Journal of Psychiatry, 43, 183-186.
81. Kop, W. J., Berman, D. S., Gransar, H., Wong, N. D., Miranda-Peats, R., White, M. D. et al. (2005). Social network and coronary artery calcification in asymptomatic individuals. Psychosomatic Medicine, 37, 343-352.
82. Kristal-Boneh, E., Raifel, M., Froom, P., & Ribak, J. (1995). Heart rate variability in health and disease. Scandinavian Journal of Work Environment and Health, 21, 85-95.
83. Krittayaphong, R., Cascio, W. E., Light, K. C., Sheffield, D., Golden, R. N., Finkel, J. B. et al. (1997). Heart rate variability in patients with coronary artery disease: Differences in patients with higher and lower depression scores. Psychosomatic Medicine, 59, 231-235.
84. Kronfol, Z. (2002). Immune dysregulation in major depression: A critical review of existing evidence. International Journal of Neuropsychopharmacology, 5, 333-343.
85. La Rovere, M. T., Bigger., J. T. Jr, Marcus, F. I., Mortara, A., & Schwartz, P. J. (1998). Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. The Lancet, 351, 478-484.
86. Lambert, G., Johansson, M., Ågren, H., & Friberg, P. (2000). Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: Evidence in support of the catecholamine hypothesis of mood disorders. Archives of General Psychiatry, 57, 787-793.
87. Legros, J. J., Chiodera, P., Geenen, V., & von Frenckell, R. (1987). Confirmation of the inhibitory influence of exogenous oxytocin in cortisol and ACTH in man: Evidence of reproducibility. Acta Endocrinologia, 114, 345-349.
88. Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990). Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New England Journal of Medicine, 323, 236-241.
89. van Londen, L., Goekoop, J. G., Kerkof, G. A., Zwinderman, K. H., Wiegant, V. M., & De Wied, D. (2001). Weak 24-h periodicity of body temperature and increased plasma vasopressin in melancholic depression. European Neuropsychopharmacology, 11, 7-14.
90. Lucki, I. (1998). The spectrum of behaviors influenced by serotonin. Biological Psychiatry, 44, 151-162.
91. Maes, M. (1995). Evidence for an immune response in major depression: A review and hypothesis. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 19, 11-38.
92. Maes, M., Lin, A., Bonaccorso, S., van Hunsel, F., Van Gastel, A., Delmeire, L. et al. (1998). Increased 24-hour uninary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatrica Scandinavica, 98, 328-335.
93. Maes, M., & Meltzer, H. Y. (1995). The serotonin hypothesis of major depression. In F. E. Bloom & D. J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress (pp. 933-944). New York: Raven Press.
94. Maier, S. F., & Watkins, L. R. (2005). Stressor controllability and learned helplessness: The roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neuroscience and Biobehavioral Reviews, 29, 829-841.
95. Mathers, C. D., & Loncar, D. (2005). Updated Projections of Global Mortality and Burden of Disease, 2002-2030: Data Sources, Methods and Results. Geneva: World Health Organization.
96. Matthews, K., Christmas, D., Swan, J., & Sorrell, E. (2005). Animal models of depression: Navigating through the clinical fog. Neuroscience and Biobehavioral Reviews, 29, 503-513.
97. Michelini, L. C., Marcelo, M. C., Amico, J., & Morris, M. (2003). Oxytocinergic regulation of cardiovascular function: Studies in oxytocin-deficient mice. American Journal of Physiology-Regulatory Integrative and Comparative Physiology, 284, H2269-H2276.
98. Monroe, S. M., & Harkness, K. L. (2005). Life stress, the "kindling" hypothesis, and the recurrence of depression: Considerations from a life stress perspective. Psychological Review, 112, 417-445.
99. Mössner, R., Mikova, O., Koutsilieri, E., Saoud, M., Ehlis, A. C., Müller, N. et al. (2007). Consensus paper of the WFSBP Task Force on Biological Markers: Biological markers in depression. World Journal of Biological Psychiatry, 8, 141-174.
100. Nalivaiko, E. (2006). 5-HT1A receptors in stress-induced cardiac changes: A possible link between mental and cardiac disorders. Clinical and Experimental Pharmacology and Physiology, 33, 1259-1264.
101. Nemeroff, C. B., Musselman, D. L., & Evans, D. L. (1998). Depression and cardiac disease. Depression and Anxiety, 8(Suppl. 1), 71-79.
102. Neumann, I. D. (2002). Involvement of the brain oxytocin system in stress coping: Interactions with the hypothamo-pituitary-adrenal axis. Progress in Brain Research, 139, 147-162.
103. Niiranen, A., Laaksonen, R., Iivanainen, M., Mattson, K., Fäkkilä, M., & Cantell, K. (1988). Behavioral assessment of patients treated with alpha-interferon. Acta Psychiatrica Scandinavica, 78, 622-626.
104. Penninx, B. W. J. H., Beekman, A. T. F., Honig, A., Deeg, D. J. H., Schoevers, R. A., van Eijk, J. T. M. et al. (2001). Depression and cardiac mortality: Results from a community-based longitudinal study. Archives of General Psychiatry, 58, 221-227.
105. Pitzalis, M. V., Iacoviello, M., Todarello, O., Fioretti, A., Guida, P., Massari, F. et al. (2001). Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction. American Heart Journal, 141, 765-771.
106. Pollak, Y., & Yirmiya, R. (2002). Cytokine-induced changes in mood and behaviour: Implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. International Journal of Neuropsychopharmacology, 5, 389-399.
107. Porges, S. W. (2007). The polyvagal perspective. Biological Psychology, 74, 116-143.
108. Porsolt, R. D., Le Pichon, M., & Jalfre, M. (1977). Depression: A new animal model sensitive to antidepressant treatments. Nature, 266, 730-732.
109. Purba, J. S., Hoogendijk, W. J., Hofman, M. A., & Swaab, D. F. (1996). Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Archives of General Psychiatry, 53, 137-143.
110. Raadsheer, F. C., van Heerikhuize, J. J., Lucassen, P. J., Hoogendijk, W. J. G., Tilders, F. J. H., & Swaab, D. F. (1995). Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. American Journal of Psychiatry, 152, 1372-1376.
111. Ramsay, S., Ebrahim, S., Whincup, P., Papacosta, O., Morris, R., Lennon, L. et al. (2008). Social engagement and the risk of cardiovascular disease mortality: Results of a prospective population based study of older men. Annals of Epidemiology, 18, 476-483.
112. Roose, S. P., Laghrissi-Thode, F., Kennedy, J. S., Nelson, J. C., Bigger., J. T. Jr, Pollock, B. G. et al. (1998). Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. Journal of the American Medical Association, 279, 287-291.
113. Rutledge, T., Linke, S. E., Olson, M. B., Francis, J., Johnson, B. D., Bittner, V. et al. (2008). Social networks and incident stroke among women with suspected myocardial ischemia. Psychosomatic Medicine, 70, 282-287.
114. Rutledge, T., Reis, S. E., Olson, M., Owens, J., Kelsey, S. F., Pepine, C. J. et al. (2004). Social networks are associated with lower mortality rates among women with suspected coronary disease: The National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation study. Psychosomatic Medicine, 66, 882-888.
115. Sanders, B. J., & Lawler, J. E. (1992). The borderline hypertensive rat (BHR) as a model for environmentally-induced hypertension: A review and update. Neuroscience and Biobehavioral Reviews, 16, 207-217.
116. Schwartz, A. R., Gerin, W., Davidson, K. W., Pickering, T. G., Brosschot, J. F., Thayer, J. F. et al. (2003). Toward a causal model of cardiovascular responses to stress and the development of cardiovascular disease. Psychosomatic Medicine, 65, 22-35.
117. Seligman, M. E. P. (1974). Depression and learned helplessness. In R. J. Friedman & M. M. Katz (Eds.), The Psychology of Depression: Contemporary Theory and Research (pp. 83-125). Washington, DC: V. H. Winston.
118. Sgoifo, A., Pozzato, C., Costoli, T., Manghi, M., Stilli, D., Ferrari, P. F. et al. (2001). Cardiac autonomic responses to intermittent social conflict in rats. Physiology and Behavior, 73, 343-349.
119. Shively, C. A., & Bethea, C. L. (2004). Cognition, mood disorders, and sex hormones. Ilar Journal, 45, 189-199.
120. Shively, C. A., Musselman, D. L., & Willard, S. L. (2009). Stress, depression, and coronary artery disease: Modeling comorbidity in female primates. Neuroscience and Biobehavioral Reviews, 33, 133-144.
121. Shively, C. A., Williams, J. K., Laber-Laird, K., & Anton, R. F. (2002). Depression and coronary artery atherosclerosis and reactivity in female cynomolgus monkeys. Psychosomatic Medicine, 64, 699-706.
122. Smith, R. S. (1991). The macrophage theory of depression. Medical Hypotheses, 35, 298-306.
123. Sole, M. J., Versteeg, D. H., de Kloet, E. R., Hussain, N., & Lixfeld, W. (1983). The identification of specific serotonergic nuclei inhibited by cardiac vagal afferents during acute myocardial ischemia in the rat. Brain Research, 265, 55-61.
124. Spriggs, D. R., Sherman, M. L., Michie, H., Arthor, K. A., Imamura, K., Wilmore, D. et al. (1988). Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase 1 and pharmacology study. Journal of the National Cancer Institute, 80, 1039-1044.
125. Steptoe, A., Owen, N., Kunz-Ebrecht, S. R., & Brydon, L. (2004). Loneliness and neuroendocrine, cardiovascular, and inflammatory stress responses in middle-aged men and women. Psychoneuroendocrinology, 29, 593-611.
126. Steptoe, A., & Whitehead, D. L. (2005). Depression, stress, and coronary heart disease: The need for more complex models. Heart, 91, 419-420.
127. Sullivan Hanley, N. R., & Van de Kar, L. D. (2003). Serotonin and the neuroendocrine regulation of the hypothalamic-pituitary-adrenal axis in health and disease. Vitamins and Hormones, 66, 189-255.
128. Suls, J., & Bunde, J. (2005). Anger, anxiety and depression as risk factors for cardiovascular disease: The problems and implications of overlapping affective dispositions. Psychological Bulletin, 131, 260-300.
129. Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005). The stress system in the human brain in depression and neurodegeneration. Ageing Research Reviews, 4, 141-194.
130. Swanson, L. W., & Sawchenko, P. E. (1980). Paraventricular nucleus: A site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology, 31, 410-417.
131. Taylor, S. E., Gonzaga, G. C., Klein, L. C., Hu, P., Greendale, G. A., & Seeman, T. E. (2006). Relation of oxytocin to psychological stress responses and hypothalamic-pituitary-adrenocortical axis activity in older women. Psychosomatic Medicine, 68, 238-245.
132. Thurston, R. C., & Kubzansky, L. D. (2009). Women, loneliness, and incident coronary heart disease. Psychosomatic Medicine, 71, 836-842.
133. Vaidya, J. G., Grippo, A. J., Johnson, A. K., & Watson, D. (2004). A comparative developmental study of impulsivity in rats and humans: The role of reward sensitivity. Annals of the New York Academy of Sciences, 1021, 395-398.
134. Van der Kooy, K., van Hout, H., Marwijk, H., Marten, H., Stehouwer, C., & Beekman, A. (2007). Depression and the risk for cardiovascular diseases: Systematic review and meta analysis. International Journal of Geriatric Psychiatry, 22, 613-626.
135. Watkins, L. L., Blumenthal, J. A., & Carney, R. M. (2002). Association of anxiety with reduced baroreflex cardiac control in patients after acute myocardial infarction. American Heart Journal, 143, 460-466.
136. Watkins, L. L., & Grossman, P. (1999). Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. American Heart Journal, 137, 453-457.
137. Weber, B., Lewicka, S., Deuschle, M., Colla, M., Vecsei, P., & Heuser, I. (2000). Increased diurnal plasma concentrations of cortisone in depressed patients. Journal of Clinical Endocrinology and Metabolism, 85, 1133-1136.
138. Wichers, M., & Maes, M. (2002). The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology, 5, 375-388.
139. Willner, P. (1997). The chronic mild stress procedure as an animal model of depression: Valid, reasonably reliable, and useful. Psychopharmacology, 134, 371-377.
140. Willner, P. (2005). Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology, 52, 90-110.
141. Willner, P., Benton, D., Brown, E., Cheeta, S., Davies, G., Morgan, J. et al. (1998). "Depression" increases "craving" for sweet rewards in animal and human models of depression and craving. Psychopharmacology, 136, 272-283.
142. Willner, P., Lappas, S., Cheeta, S., & Muscat, R. (1994). Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole. Psychopharmacology, 115, 454-462.
143. Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987). Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology, 93, 358-364.
144. Windle, R. J., Shanks, N., Lightman, S. L., & Ingram, C. D. (1997). Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology, 138, 2829-2834.
145. Wulsin, L. R., & Singal, B. M. (2003). Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosomatic Medicine, 65, 201-210.
146. Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A. et al. (2001). The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain Behavior and Immunity, 15, 199-226.